Cargando…
Increased Intrathecal B and Plasma Cells in Patients With Anti-IgLON5 Disease: A Case Series
BACKGROUND AND OBJECTIVES: Despite detection of autoantibodies, anti-IgLON5 disease was historically considered a tau-associated neurodegenerative disease, with limited treatment options and detrimental consequences for the patients. Observations in increasing case numbers hint toward underlying inf...
Autores principales: | Strippel, Christine, Heidbreder, Anna, Schulte-Mecklenbeck, Andreas, Korn, Lisanne, Warnecke, Tobias, Melzer, Nico, Wiendl, Heinz, Pawlowski, Matthias, Gross, Catharina C., Kovac, Stjepana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759718/ https://www.ncbi.nlm.nih.gov/pubmed/35031586 http://dx.doi.org/10.1212/NXI.0000000000001137 |
Ejemplares similares
-
Isolated dysphagia as initial sign of anti-IgLON5 syndrome
por: Schröder, Jens Burchard, et al.
Publicado: (2016) -
IgLON5 disease responsive to immunotherapy
por: Bonello, Michael, et al.
Publicado: (2017) -
Subacute encephalitis with recovery in IgLON5 autoimmunity
por: Ramanan, Vijay K., et al.
Publicado: (2018) -
Patients’ IgLON5 autoantibodies interfere with IgLON5-protein interactions
por: Landa, Jon, et al.
Publicado: (2023) -
Corrigendum: Patients’ IgLON5 autoantibodies interfere with IgLON5–protein interactions
por: Landa, Jon, et al.
Publicado: (2023)